Share of units sold of Rx oral solid opioids in Canada 2017 by drug

In the year 2017, the oral solid opioid oxycodone had a market share of 21 percent out of all units of prescription oral solid opioids sold in Canada. The opioid with the largest market share based on units sold was codeine, with 52 percent.

Percentage of the prescription oral solid opioid market in Canada based on units sold in 2017, by drug

Percentage of units sold
Hydromorphone 14%
Oxycodone 21%
Morphine 6%
Codeine 52%
Tramadol 6%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

January 2019

Region

Canada

Survey time period

2017

Supplementary notes

Statistic includes prescription retail and hospital markets.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.